Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 37, Issue 2, 2009, Pages 69-77

  Gu, Jingsong ^a   Chang, Thomas Ming Swi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antioxidant; Blood substitutes; Catalase; Enzyme; Erythrocyte; Hemoglobin; Hydrogen peroxide; Ischemia reperfusion; Nanobiotechnology; Oxygen radicals; Polyhemoglobin; Red blood cells; Superoxide; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; CATALASE; ERYTHROCYTE; ISCHEMIA-REPERFUSION; OXYGEN RADICALS; POLYHEMOGLOBIN; RED BLOOD CELLS; SUPEROXIDE; SUPEROXIDE DISMUTASE;

BLOOD; BLOOD SUBSTITUTES; CATALYSTS; CELLS; ENZYMES; HEMOGLOBIN; HEMOGLOBIN OXYGEN SATURATION; HYDROGEN; HYDROGEN PEROXIDE; LEAKAGE (FLUID); NANOBIOTECHNOLOGY; OXIDATION;

OXYGEN;

ANTIOXIDANT; CATALASE; ERYTHROCYTE ENZYME; OXYGEN RADICAL; PYRIDOXYLPOLYHEMOGLOBIN; RECOMBINANT ENZYME; SUPEROXIDE DISMUTASE;

ARTICLE; ENZYME ISOLATION; ERYTHROCYTE MEMBRANE; EXTRACTION; HEART MUSCLE REPERFUSION; NANOBIOTECHNOLOGY; OXYGEN AFFINITY; REPERFUSION INJURY;

ANIMALS; ANTIOXIDANTS; CATALASE; CATTLE; CELL EXTRACTS; CYTOPROTECTION; ERYTHROCYTES; HEMOGLOBINS; NANOTECHNOLOGY; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SUPEROXIDE DISMUTASE;

EID: 62249221412     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.1080/10731190902742240     Document Type: Article

References (14)

1. Alayash, A.I., D'Agnillo, F., Buehler, P.W. (2007). First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives. Expert Opin. Biol. Ther. 7(5):665-675.
2. Bannister, J.V., Bannister, W.H. (1984). Isolation and characterization of superoxide dismutase. Methods in Enzymology 105:88-93.
3. Beauchamp, C., Fridovich, I. (1971). Superoxide dismutase: improved assays and an assay applicable to acrylamide gels 1. Anal. Biochem. 44:276-287.
4. Chang, T.M.S. (1971). Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by microencapsulation followed by cross-linking with glutaraldehyde. Biochem Biophys Res Common. 44(6):1531-1536.
5. Chang, T.M.S. (1997). Blood Substitutes: Principles, Methods, Products and Clinical Trials. Vol. 1. McGill University, Montreal (full text and updates available for free online viewing at www.artcell.mcgill.ca).
6. Chang, T.M.S. (2007). Monograph on ARTIFICIAL CELLS: Biotechnology, Nanotechnology, Blood Substitutes, Regenerative Medicine, Bioencapsulation, Cell/Stem Cell Therapy. World Science Publisher, Singapore.
7. Chang, T.M.S. (2008). Nanobiotechnological modification of hemoglobin and enzymes from this laboratory. Biochimica et Biophysica Acta: Proteins & Proteomics 1784:1435-144.
8. Chang, T.M.S. (2009). Nanobiotechnology for hemoglobin based blood substitutes. Critical Care Clinics (in press).
9. D'Agnillo, F., Chang, T.M.S. (1998). PolyHb-superoxide dismutase. catalase as a blood substitute with antioxidant properties. Nature Biotechnology 16(7):667-671.
10. Fossati, P., Prencipe, L., Berti, G. (1980). Use of 3,5-dichloro-2- hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clinical Chemistry 26:227-231.
11. Giulivi, C., Davies, K.J.A. (1990). A novel antioxidant role for hemoglobin: the comproportionation of ferrylhemoglobin with oxyhemoglobin. J. Biol. Chem. 265:19453-19460.
12. Gould, S. A. et al. (2002). The life-sustaining capacity of human polymerized Hb when red cells might be unavailable. J. Am. Coll. Surg. 195:445-452.
13. Moore, E.E. et al. (2009). Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 208:1-13.
14. Pearce, L.B., Gawryl, M.S., Rentko, V.T., Moon-Massat, P.F. and Rausch, C.W. (2006). HBOC-201 (Hb Glutamer-250 (Bovine), hemopure): clinical studies. In Winslow, R. (Ed.), Blood Substitutes, Academic Press, San Diego, pp. 437-4509.